HIV / AIDS

Colleen Kelley, MD, MPH, describes barriers to the implementation of HIV pre-exposure prophylaxis.

A recent report discusses the expansion of pre-exposure prophylaxis into the 35 PEPFAR supported early program adopters from October 2016 to September 2018.

New research pinpoints some of the factors involved in HIV reemergence after cessation of antiretroviral therapy, as well as possible ways to stop the process.

Clinicians accustomed to HIPAA guidelines may not be aware of changes in confidentiality when they make contact with school health care services.

Jason Tokumoto, MD, reflects on the ways people respond to HIV diagnosis.

Concerns over the possibility of increased neural-tube defects and weight gain on dolutegravir are outweighed by the much lower rates of HIV transmission from mother to baby than are seen with efavirenz.

The NIH has begun the first clinical trial evaluating the safety of a monthly dapivirine ring used to prevent HIV among pregnant women in eastern and southern Africa.

Clinicians must identify when additional pounds cross the line of diminishing return.

People living with HIV who don’t receive early intervention and primary care end up with a disproportionate share of health care costs, according to a new study that examined barriers to care and costs at a Dublin hospital.

PWID are unlikely to receive testing for HIV and hepatitis C, according to a new study that found that 8.5% were tested for HIV and 7.7% were tested for HCV within 1 year of a clinical encounter consistent with injection drug use.

Jason Tokumoto, MD, explains the need to look beyond nonadherence and understand a patient with HIV as a complex person.

The rising price of antiretroviral therapy for people living with HIV in the United States is a barrier to adherence. It also blunts efforts to achieve higher rates of viral suppression.

Jason Tokumoto, MD, discusses the evolution of HIV treatment.

Less than 1 in 4 teenage boys considered at-risk ever received an HIV test in a recent study.

February 7th is commemorated each year to highlight the impact that HIV and AIDS has on the black or African American population in the United States.

HIV-2 infections remain rare in the United States, but the CDC continues to recommend an HIV-1/HIV-2 differentiation test as a second step in testing.

NIAID and partner organizations have discontinued HIV vaccination in a South Africa based experimental trial.

A new study provides evidence that more needs to be done to meet the needs of children in rural Zimbabwe who are exposed to HIV.

Regardless of HIV status, frailty was a strong predictor for mortality and comorbidity for middle-aged adults.

Through the platform providers, consumers, and procurers will have access to full prescribing inserts and FDA-reviewed product labeling which will provide additional important information to patients and providers.

Daniel Chastain, PharmD, BCIDP, discusses how antiretroviral stewardship might practically be implemented in the context that antimicrobial stewardship as a whole is often underdeveloped.

Max Brito, MD, MPH, explains the value of bringing safe, confidential, and non-stigmatizing HIV treatment to the community at IDWeek2019.

Standalone HIV testing centers in San Diego County, California, have been largely effective at reaching people at high risk of infection, according to a new study that also identified areas where targeted testing efforts may be beneficial.

The CDC reports transgender women diagnosed with HIV are less likely to receive partner services, compared to other people receiving the same diagnosis.

Sexual risk behavior is the strongest predictor of syphilis among HIV-infected MSM and the risk of infection doesn’t decrease with repeated episodes of the infection, a new study found.